Coverage
-
July 05, 2016
The U.S. Securities and Exchange Commission on Monday urged an Illinois federal judge to bar the former leader of a drug company whose sole product was derived from goat's blood from serving on public companies' boards, saying his bid to soften his penalties is counter to his jury verdict for securities fraud.
6 other articles on this case.
View all »